China Shineway Pharmaceutical Group Ltd banner
C

China Shineway Pharmaceutical Group Ltd
OTC:CSWYF

Watchlist Manager
China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
Watchlist
Price: 1.004 USD Market Closed
Market Cap: $758.4m

Cash Flow Statement

Cash Flow Statement
China Shineway Pharmaceutical Group Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2004 Jun-2005 Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Net Income
281
0
343
0
387
0
576
0
476
0
884
0
992
0
950
0
800
0
860
0
864
0
797
0
695
0
588
0
669
0
643
0
395
0
720
0
917
0
1 240
0
1 146
0
Depreciation & Amortization
22
0
26
0
30
0
32
0
36
0
45
0
53
0
66
0
78
0
98
0
144
0
162
0
191
0
195
0
197
0
205
0
208
0
182
0
186
0
177
0
69
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
26
0
15
6
4
2
6
7
4
1
0
(1)
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
0
0
(12)
0
(45)
0
24
0
93
0
(177)
0
(49)
0
(74)
0
(81)
0
(74)
0
(81)
0
(104)
0
(97)
0
(116)
0
(133)
0
(85)
0
116
0
(98)
0
(126)
0
(120)
0
(145)
0
Cash Taxes Paid
14
0
6
0
41
0
61
0
104
0
108
0
137
0
225
0
155
0
157
0
166
0
172
0
102
0
143
0
140
0
158
0
119
0
145
0
157
0
271
0
328
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
7
0
0
0
0
0
0
0
0
2
15
17
5
1
1
1
0
3
5
6
9
Change in Working Capital
(72)
150
102
515
45
304
(230)
363
(200)
927
305
804
(417)
420
(457)
613
(162)
658
(364)
706
(154)
(226)
(111)
(171)
(56)
685
(175)
509
(201)
396
(394)
483
(81)
677
(101)
772
133
982
(365)
1 175
(106)
965
Cash from Operating Activities
231
N/A
282
+22%
458
+62%
515
+13%
417
-19%
304
-27%
402
+32%
363
-10%
405
+12%
927
+129%
1 057
+14%
804
-24%
579
-28%
420
-28%
485
+16%
613
+26%
636
+4%
658
+3%
520
-21%
706
+36%
773
+10%
701
-9%
745
+6%
685
-8%
734
+7%
685
-7%
491
-28%
509
+4%
533
+5%
396
-26%
368
-7%
483
+31%
639
+32%
677
+6%
703
+4%
772
+10%
1 110
+44%
982
-11%
933
-5%
1 175
+26%
963
-18%
965
+0%
Investing Cash Flow
Capital Expenditures
(22)
0
(73)
0
(23)
(45)
(93)
(73)
(84)
(166)
(221)
(226)
(369)
(457)
(397)
(397)
(369)
(303)
(262)
(199)
(168)
(171)
(127)
(115)
(107)
(96)
(92)
(122)
(140)
(95)
(91)
(87)
(66)
(69)
(94)
(124)
(129)
(181)
(144)
(103)
(140)
(166)
Other Items
1
(127)
(63)
(17)
34
30
39
51
49
53
(47)
(224)
132
198
68
216
79
58
(414)
(616)
396
832
(2)
(306)
27
159
176
161
253
237
161
(80)
(240)
330
489
126
84
114
95
187
(132)
229
Cash from Investing Activities
(22)
N/A
(139)
-543%
(136)
+2%
(17)
+87%
11
N/A
(15)
N/A
(54)
-259%
(22)
+59%
(36)
-61%
(114)
-220%
(268)
-136%
(449)
-67%
(237)
+47%
(259)
-9%
(328)
-27%
(181)
+45%
(290)
-60%
(245)
+15%
(676)
-175%
(815)
-21%
228
N/A
662
+190%
(129)
N/A
(421)
-226%
(80)
+81%
63
N/A
84
+34%
39
-54%
113
+189%
142
+26%
70
-51%
(167)
N/A
(306)
-83%
261
N/A
395
+52%
2
-100%
(45)
N/A
(67)
-47%
(50)
+26%
83
N/A
(272)
N/A
63
N/A
Financing Cash Flow
Net Issuance of Common Stock
1 007
0
(10)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
685
0
(700)
(200)
0
0
0
0
0
0
(2)
394
605
(34)
(616)
(377)
(8)
(8)
293
293
22
22
(10)
Cash Paid for Dividends
(32)
0
(83)
0
(182)
(281)
(190)
(314)
(331)
(207)
(182)
(306)
(314)
(331)
(331)
(306)
(306)
(265)
(265)
(273)
(273)
(273)
(273)
(265)
(265)
(265)
(265)
(263)
(261)
(254)
(249)
(244)
(241)
(241)
(453)
(453)
(242)
(317)
(317)
(408)
(408)
(355)
Other
(333)
6
(7)
(192)
0
0
0
0
0
0
0
(16)
0
17
1
0
0
0
0
(10)
0
(8)
(1)
0
0
0
0
(129)
(304)
(333)
(246)
(138)
(55)
(3)
1
(1)
(1)
(0)
(3)
(5)
(6)
(9)
Cash from Financing Activities
642
N/A
1 013
+58%
(100)
N/A
(192)
-93%
(182)
+5%
(182)
N/A
(190)
-5%
(314)
-65%
(331)
-5%
(207)
+38%
(182)
+12%
(322)
-77%
(314)
+3%
(314)
+0%
(330)
-5%
(306)
+7%
(306)
N/A
(265)
+13%
235
N/A
402
+71%
(605)
N/A
(981)
-62%
(474)
+52%
(265)
+44%
(265)
0%
(265)
+0%
(265)
0%
(391)
-48%
(565)
-45%
(589)
-4%
(101)
+83%
224
N/A
(330)
N/A
(861)
-161%
(829)
+4%
(462)
+44%
(250)
+46%
(25)
+90%
(27)
-9%
(391)
-1 362%
(392)
0%
(374)
+5%
Change in Cash
Effect of Foreign Exchange Rates
0
0
(21)
(21)
(12)
(12)
(62)
(78)
(132)
(47)
125
50
2
8
(3)
(1)
0
1
0
0
(0)
(2)
(4)
(1)
3
0
4
4
(1)
(1)
(2)
(3)
(6)
(8)
(7)
(3)
6
13
6
3
(47)
(28)
Net Change in Cash
852
N/A
1 156
+36%
201
-83%
285
+42%
234
-18%
95
-59%
97
+1%
(51)
N/A
(93)
-81%
560
N/A
733
+31%
82
-89%
31
-63%
(145)
N/A
(176)
-22%
125
N/A
40
-68%
148
+273%
80
-46%
293
+268%
396
+35%
381
-4%
138
-64%
(2)
N/A
392
N/A
484
+23%
314
-35%
161
-49%
79
-51%
(51)
N/A
335
N/A
537
+61%
(3)
N/A
68
N/A
263
+284%
309
+18%
821
+165%
903
+10%
863
-5%
870
+1%
251
-71%
626
+149%
Free Cash Flow
Free Cash Flow
209
N/A
282
+35%
385
+36%
515
+34%
394
-23%
259
-34%
309
+19%
290
-6%
321
+11%
761
+137%
836
+10%
579
-31%
211
-64%
(37)
N/A
89
N/A
216
+144%
267
+24%
354
+33%
258
-27%
507
+97%
605
+19%
531
-12%
617
+16%
570
-8%
627
+10%
589
-6%
399
-32%
388
-3%
393
+1%
301
-23%
277
-8%
397
+43%
573
+44%
608
+6%
610
+0%
648
+6%
980
+51%
801
-18%
788
-2%
1 072
+36%
823
-23%
799
-3%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett